Clinical Value of Absolute Quantification of Myocardial Perfusion With 15O-Water in Coronary Artery Disease
暂无分享,去创建一个
Mika Teräs | Juhani Knuuti | Juhani Airaksinen | Antti Saraste | Mikko Pietilä | H. Sipilä | J. Knuuti | J. Airaksinen | M. Teräs | S. Kajander | A. Saraste | M. Pietilä | M. Saraste | J. Hartiala | Maija Mäki | Heikki Ukkonen | M. Mäki | Sami A Kajander | Esa Joutsiniemi | Markku Saraste | Hannu T Sipilä | Jaakko Hartiala | E. Joutsiniemi | H. Ukkonen
[1] M Teräs,et al. Low radiation dose imaging of myocardial perfusion and coronary angiography with a hybrid PET/CT scanner , 2009, Clinical physiology and functional imaging.
[2] A. Luxen,et al. Direct Comparison of [13N]Ammonia and [150]Water Estimates of Perfusion With Quantification of Regional Myocardial Blood Flow by Microspheres , 1993, Circulation.
[3] Paul E. Christian,et al. Nuclear Medicine and PET: Technology and Techniques , 2003 .
[4] Nicola Fox,et al. Cardiovascular system. , 2007, Nursing Standard.
[5] J. van den Hoff,et al. Quantitative myocardial perfusion PET combined with coronary anatomy derived from CT angiography: validation of a new fusion and visualisation software. , 2009, Zeitschrift fur medizinische Physik.
[6] H. Sipilä,et al. Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.
[7] J. Viikari,et al. Coronary flow reserve in young men with familial combined hyperlipidemia. , 1999, Circulation.
[8] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[9] William Wijns,et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. , 2005, Journal of the American College of Cardiology.
[10] Akira Kitabatake,et al. Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: A study using oxygen 15-labeled water PET , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[11] P. Kaufmann,et al. Myocardial blood flow measurement by PET: technical aspects and clinical applications. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] T. Masuoka,et al. Quantitative measurement of regional myocardial blood flow in patients with coronary artery disease by intravenous injection of13N-ammonia in positron emission tomography , 2004, European Journal of Nuclear Medicine.
[13] Juhani Knuuti,et al. Quantification of myocardial blood flow will reform the detection of CAD , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[14] S. Nekolla,et al. Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model , 2009, Circulation.
[15] Terrence D. Ruddy,et al. Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[16] Kenneth A Ellenbogen,et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, Journal of the American College of Cardiology.
[17] O Muzik,et al. Early Detection of Abnormal Coronary Flow Reserve in Asymptomatic Men at High Risk for Coronary Artery Disease Using Positron Emission Tomography , 1994, Circulation.
[18] Georges El Fakhri,et al. QDA: An automated graphical software for absolute quantitation of regional myocardial blood flow , 2007 .
[19] Georges El Fakhri,et al. Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET , 2009, Journal of Nuclear Medicine.
[20] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.
[21] N. Pijls. Optimum guidance of complex PCI by coronary pressure measurement , 2004, Heart.
[22] J. Knuuti,et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas™) , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[23] A. Fischman,et al. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. , 2009, JACC. Cardiovascular imaging.
[24] N. Simionescu,et al. The Cardiovascular System , 1983 .
[25] M. Schwaiger,et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. , 1998, Journal of the American College of Cardiology.
[26] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.